HealthCor Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-279,810
Closed -$47.9M 69
2021
Q4
$47.9M Buy
279,810
+272,530
+3,744% +$44.6M 2.6% 13
2021
Q3
$1.18M Buy
+7,280
New +$1.24M 0.05% 67
2021
Q1
Sell
-435,010
Closed -$68.5M 93
2020
Q4
$68.5M Buy
+435,010
New +$64.2M 2.64% 18
2020
Q1
Sell
-687,960
Closed -$100M 55
2019
Q4
$100M Buy
687,960
+344,420
+100% +$46.7M 3.58% 7
2019
Q3
$44.4M Buy
+343,540
New +$45.3M 1.68% 25
2018
Q1
Sell
-194,610
Closed -$27.2M 50
2017
Q4
$27.2M Sell
194,610
-488,440
-72% -$68M 0.89% 28
2017
Q3
$88.8M Buy
+683,050
New +$90.5M 2.98% 11

Other funds holding JNJ

HealthCor Management's JNJ Position: Q1 2022 in Review

HealthCor Management sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 279,810 shares — an estimated $47.9M sold.

HealthCor Management first reported a position in JNJ in Q3 2017 and held it in 7 quarters. The position peaked at $100M in Q4 2019. 3,677 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • HealthCor Management reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
  • HealthCor Management sold 279,810 Johnson & Johnson shares in Q1 2022, an estimated $47.9M.
  • HealthCor Management first reported a position in Johnson & Johnson in Q3 2017 and held it in 7 quarters.
  • HealthCor Management's Johnson & Johnson position peaked at $100M in Q4 2019.
  • 3,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on HealthCor Management's 13F filing for Q1 2022, filed 16 May 2022.